Neurology Minute
1,925 episodes — Page 21 of 39
Continuum: Alzheimer Disease - Part 3
In part 3 of a 3-part series, Eric M. McDade, DO, discusses his article, "Alzheimer Disease" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/AlzDisease.
Continuum: Alzheimer Disease - Part 2
In part 2 of a 3-part series, Eric M. McDade, DO, discusses his article, "Alzheimer Disease" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/AlzDisease.
Continuum: Alzheimer Disease - Part 1
In part 1 of a 3-part series, Eric M. McDade, DO, discusses his article, "Alzheimer Disease" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/AlzDisease.
Careers in Neurology: Health Services Research
Dr. Katrina Ignacio discusses the emerging subspecialty of health services research (HSR).
Maternal Serotonergic Antidepressant Use in Pregnancy and Risk of Seizures in Children
Kelsey Kathleen Wiggs discusses her article in Neurology, "Maternal Serotonergic Antidepressant Use in Pregnancy and Risk of Seizures in Children". Show references: https://n.neurology.org/content/98/23/e2329
Ted Burns: A Podcast In Memoriam
A tribute to Dr. Ted Burns, the founder, and creator of the Neurology Podcast and the Neurology Minute, who recently passed away after a 9-year battle with cancer.
Optic Nerve MRI
Dr. Justin Abbatemarco discusses the Neurology: Neuroimmunology & Neuroinflammation article "Optic Nerve Lesion Length at the Acute Phase of Optic Neuritis is Predictive of Retinal Neuronal Loss." Show references: https://nn.neurology.org/content/9/2/e1135
GABAa Encephalitis
Dr. Justin Abbatemarco discusses the features of anti-γ-aminobutyric acid type A (anti-GABAA) receptor encephalitis.
Antisense Oligonucleotide Suppression of Mutant C9orf72
Dr. Robert Brown discusses the Nature Medicine article, "Suppression of Mutant C9orf72 Expression by a Potent Mixed Backbone Antisense Oligonucleotide". Show references: https://www.nature.com/articles/s41591-021-01557-6
Cognitive Syndromes Associated with COVID
Dr. Avi Nath discusses COVID brain fog and other cognitive syndromes. Show references: https://www.washingtonpost.com/health/2022/03/27/covid-brain-fog-chemo-brain-alzheimers-disease/
The Value of Neuroimaging in Dementia Diagnosis - Part 3
In part 3 of a 3-part series, Cyrus A. Raji, MD, Ph.D., discusses his article, "The Value of Neuroimaging in Dementia Diagnosis" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/NeuroimagDementia.
The Value of Neuroimaging in Dementia Diagnosis - Part 2
In part 2 of a 3 part series, Cyrus A. Raji, MD, Ph.D., discusses his article, "The Value of Neuroimaging in Dementia Diagnosis" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/NeuroimagDementia.
The Value of Neuroimaging in Dementia Diagnosis - Part 1
In part 1 of a 3 part series, Cyrus A. Raji, MD, Ph.D., discusses his article, "The Value of Neuroimaging in Dementia Diagnosis" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/NeuroimagDementia.
Careers in Neurology: Clinical Development
Dr. Katrina Ignacio discusses the emerging subspecialty of clinical development.
Corticosteroids in LGI1 Antibody Encephalitis
Dr. Sarosh Irani discusses the use of corticosteroids as a first-line agent in the treatment of LGI1-antibody encephalitis.
NINDS Mission and Clinical Neurology with Walter Koroshetz
Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke, discusses the NINDS's mission and clinical neurology.
Neurosarcoidosis - Part 2
Dr. Shuvro Roy discusses Neurosarcoidosis in part 2 of a 2 part series.
Neurosarcoidosis - Part 1
Dr. Shuvro Roy discusses Neurosarcoidosis in part 1 of a 2 part series.
Maintenance Intravenous Immunoglobulin Prevents Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Dr. Rae Bacharach discusses the Neurology Today article, "Maintenance Intravenous Immunoglobulin Prevents Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease". Show references: https://journals.lww.com/neurotodayonline/Fulltext/2022/05190/Maintenance_Intravenous_Immunoglobulin_Prevents.1.aspx
Medicare Limitation of Aduhelm
Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, discusses Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.
EEG Patterns and Neurofilament Light After Cardiac Arrest
Dr. Linnéa Grindegård discusses the association between EEG patterns and serum neurofilament light as a marker of neuroaxonal injury after cardiac arrest.
Adult Opsoclonus-Myoclonus Syndrome
Dr. Justin Abbatemarco discusses Adult Opsoclonus-Myoclonus Syndrome.
Pediatric Opsoclonus-Myoclonus Syndrome
Dr. Justin Abbatemarco discusses Pediatric Opsoclonus-Myoclonus Syndrome.
Early Detection of Parkinson's Disease
Dr. Halley Alexander discusses the Neurology Today article, "Potential Parkinson's Risks Found Years Before Diagnosis". Show references: https://journals.lww.com/neurotodayonline/Fulltext/2022/05050/Potential_Parkinson_s_Risks_Found_Years_Before.3.aspx
Race-Ethnic Disparities in Stroke Thrombolysis
Dr. Scott Mendelson discusses racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke. Show references: https://n.neurology.org/content/early/2022/02/28/WNL.0000000000200138
A Review of L-arginine in MELAS
Dr. Gráinne Gorman discusses the use of L-arginine in the treatment of mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Show references: https://n.neurology.org/content/early/2022/04/14/WNL.0000000000200299
Post-Concussion Headache
Dr. Meeryo Choe discusses post-concussion headaches, from the May NeuroPanels webinar series. Show references: https://learning.aan.com/diweb/catalog/item?id=9188210
Development of New or Enlarging MRI Lesions Rare in MOGAD
Dr. Stephanie Syc-Mazurek discusses her abstract, "Development of new or enlarging MRI lesions outside of attacks is rare in myelin oligodendrocyte glycoprotein antibody-associated disease". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-001680.html
Fentanyl Exposure
Dr. Derek Stitt discusses facts and the misinformation surrounding fentanyl exposure.
Pure Sleep Epilepsy in Patients With First Seizure
Dr. Elaine Pang discusses the identification and characterization of pure sleep epilepsy after first-ever seizures from sleep in adults. Show references: https://n.neurology.org/content/98/18/e1857.abstract
Quality of Life for Patients with Parkinson's Disease
Dr. Meredith Bock discusses her paper about the association of motor, non-motor, and behavioral symptoms with health-related quality of life in people with Parkinson's disease. Show references: https://n.neurology.org/content/98/22/e2194
Continuum: Epilepsy
Dr. Nathalie Jetté shares what she learned as the guest editor of the April 2022 Continuum issue on Epilepsy.
Acute Symptomatic Seizures Secondary to MOGAD
Dr. Mayra Montalvo discusses her abstract, "Acute Symptomatic Seizures Secondary to Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder" [MOGAD]. Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-003525.html
Neurodegeneration in Pro Football Players - Part 2
Dr. Ann McKee continues her discussion on her recent study, which found that NFL players are at a higher risk for amyotrophic lateral sclerosis (ALS). Show references:https://journals.lww.com/neurotodayonline/fulltext/2022/02030/professional_football_players_are_at_a_higher_risk.5.aspx
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia In Children
Dr. Ming Lim discusses the diagnosis and management of opsoclonus myoclonus ataxia syndrome (OMAS) in children. Show references: https://nn.neurology.org/content/9/3/e1153
Neurology on the Hill: Telehealth
Dr. Nassim Zecavati discusses one of the 2022 Neurology on the Hill issues: Extend Telehealth Flexibilities. Follow the event on social media using #NOH22. Show references: https://www.aan.com/events/neurology-on-the-hill
Neurology on the Hill: Barriers to Care
Dr. Tyler Allison discusses one of the 2022 Neurology on the Hill issues: Address Overly Burdensome Barriers to Care. Follow the event on social media using #NOH22. Show references: https://www.aan.com/events/neurology-on-the-hill
Neurology on the Hill: Support the Neurology Workforce
Dr. Umer Najib discusses one of the 2022 Neurology on the Hill issues: Neurology Workforce. Follow the event on social media using #NOH22. Show references: https://www.aan.com/events/neurology-on-the-hill
The High Cost of Multiple Sclerosis
Dr. Rae Bacharach discusses the Neurology Today article, "Multiple Sclerosis Costs More Than $85 Billion Annually, New Study Finds the Policy Changes That Could Fix That". Show references: https://journals.lww.com/neurotodayonline/Fulltext/2022/05050/Multiple_Sclerosis_Costs_More_Than__85_Billion.4.aspx
Neurodegeneration in Pro Football Players
Dr. Ann McKee discusses her recent study, which found that NFL players are at a higher risk for amyotrophic lateral sclerosis (ALS). Show references:https://journals.lww.com/neurotodayonline/fulltext/2022/02030/professional_football_players_are_at_a_higher_risk.5.aspx
Peripheral Neuropathy Evaluations of Patients with Prolonged Long COVID
Dr. Anne Oaklander discusses the association of long COVID with incident polyneuropathy affecting the small-fiber axons. Show references:https://nn.neurology.org/content/9/3/e1146
Approach to the Medical Treatment of Epilepsy - Part 2
In part 2 of a 2 part series, Francesco Brigo, MD, discusses his article, "Approach to the Medical Treatment of Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/MedTreatEpilepsy.
Approach to the Medical Treatment of Epilepsy - Part 1
In part 1 of a 2 part series, Francesco Brigo, MD, discusses his article, "Approach to the Medical Treatment of Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/MedTreatEpilepsy.
Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy
Dr. Nancy Newman discusses her abstract, "The Phase III REFLECT Trial: Efficacy and Safety of Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-000928.html
Neuromodulation Restores Function in Spinal Cord Injury
Dr. Andreas Rowald discusses the efficacy of activity-dependent spinal cord neuromodulation, which was shown to rapidly restore trunk and leg motor functions in patients with spinal cord injury after complete paralysis.
Cardiac Arrhythmia in Patients with Drug-Resistant Epilepsy
Dr. Shobi Sivathamboo discusses the incidence of serious cardiac arrhythmias detected by subcutaneous cardiac monitors in patients with chronic drug-resistant epilepsy. Show references: https://n.neurology.org/content/early/2022/04/06/WNL.0000000000200173"
Genetics and Neuroinflammation, Considerations for the Clinician - Part 4
Dr. Justin Abbatemarco discusses Alexander disease.
Genetics and Neuroinflammation, Considerations for the Clinician - Part 3
Dr. Justin Abbatemarco discusses Adrenoleukodystrophy (ALD).
PNES Semiology
Dr. Michael Kentris discusses psychogenic non-epileptic spells [PNES].
Prognosis and Treatment of Spinal Cord Sarcoidosis
Dr. Antoine Gavoille discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis. Show references: https://n.neurology.org/content/98/14/e1479